Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2021-04-06 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
易明医药2020年度业绩快报内部审计报告
Regulatory Filings
2021-04-06 Chinese
关于公司本次非公开发行股票涉及关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a non-public issuance of shares involving a related party transaction. It details the share issuance plan, the related party's background, pricing principles, approvals, and independent directors' opinions. The document is a formal announcement of a capital raising event involving share issuance and related party disclosures. It does not contain financial statements or detailed financial performance data, nor is it a transcript, report, or presentation. The content fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes.
2021-04-06 Chinese
易明医药前次募集资金使用情况鉴证报告
Regulatory Filings
2021-04-06 Chinese
独立董事关于第二届董事会第十八次会议相关事项的事前认可意见
Capital/Financing Update Classification · 95% confidence The document is a formal opinion from independent directors regarding the company's non-public issuance of A shares, including approval of the issuance plan, pricing, related party transactions, and subscription agreements. It references compliance with Chinese securities laws and regulations and is dated April 5, 2021. The content focuses on pre-approval and opinions related to a capital raising activity (non-public stock issuance). There are no financial statements or detailed financial results presented, but rather a governance and regulatory compliance opinion related to a financing event. This fits best under Capital/Financing Update (CAP) as it concerns a capital raising transaction and related approvals.
2021-04-06 Chinese
监事会关于公司2020年度非公开发行股票的审核意见
Capital/Financing Update Classification · 95% confidence The document is a supervisory board's audit opinion on the company's 2021 non-public stock issuance. It discusses compliance with laws and regulations, the feasibility of the stock issuance plan, use of raised funds, shareholder interests, and related commitments. It is not a full financial report but an official announcement related to capital raising activities. The document length is short (1754 characters), and it focuses on the review and approval of a non-public stock issuance, which aligns with capital/financing updates rather than an annual report or audit report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-04-06 Chinese
公司未来三年（2021-2023）股东回报规划
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement from a company about its shareholder return plan for the next three years (2021-2023). It discusses dividend policies, profit distribution principles, decision-making procedures, and conditions for cash and stock dividends. The document is not a financial report, earnings release, or regulatory filing per se, but rather a formal announcement of the company's planned dividend and shareholder return strategy. It does not contain financial statements or audit opinions, nor is it a report publication announcement. Given the content focuses on dividend policy and shareholder returns, it fits best under the category of Notice of Dividend Amount (DIV), which covers announcements about dividend amounts, payment dates, and related shareholder information. The document length is 3143 characters, which is relatively short but contains substantive policy details rather than just a brief notice. Therefore, the classification is DIV with high confidence.
2021-04-06 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.